「pr」の検索結果
230件：161～165件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) Pranoprofeninflammati...
http://www.senju.co.jp/english/rd/pipeline.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please chang
http://www.senju.co.jp/english/rd/ -
お知らせ | 千寿製薬株式会社
of Distribution of Software for Dry-eye Analysis（PDF） September 3, 2024 Acquisition of Marketing Approval for “ Mytear LUMIFY”（PDF） July 26, 2024 Launch of Distribution of RET-700（PDF） July 16, 2024 ...
http://www.senju.co.jp/english/news/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
8日～7月1日 開催地：Rome, italy Establishment of open-angle ocular hypertension model by conditional over expression of autotaxinin mice eyes Shota Shimizu1, 2, Megumi Honjo1, Liu Mengxuan1, Makoto Aihara1 1 ...
http://www.senju.co.jp/english/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
8日～7月1日 開催地：Rome, italy Establishment of open-angle ocular hypertension model by conditional over expression of autotaxinin mice eyes Shota Shimizu1, 2, Megumi Honjo1, Liu Mengxuan1, Makoto Aihara1 1 ...
https://www.senju.co.jp/english/rd/society/